ACE Inhibitor Heart Disease Kidney Disease 
Open Heart
APRIL 24, 2024
Frailty, chronic kidney disease and ischaemic heart disease increased significantly versus the first period (p<0.001). were on a beta blocker and on an ACE inhibitor/angiotensin receptor blocker/angiotensin receptor-neprilysin inhibitor, respectively. and 29.2%, p<0.001).
DAIC
APRIL 6, 2024
As evidence has mounted pointing to their benefits in reducing heart failure and other forms of heart disease, researchers have sought to determine whether these drugs could help to prevent heart failure even in people without diabetes or chronic kidney disease.
DAIC
APRIL 6, 2024
As evidence has mounted pointing to their benefits in reducing heart failure and other forms of heart disease, researchers have sought to determine whether these drugs could help to prevent heart failure even in people without diabetes or chronic kidney disease.
Expert insights. Personalized for you.
52 
Let's personalize your content